SLC40A1 and anemia (phenotype): We characterize its ferroportin at the DNA and protein levels, assess its constitutive tissue transcription levels, evaluate variations in its expression during a variety of experimental conditions, including iron overload, anemia, and infection, and investigate the effects of the administration of hepcidin peptides in its expression.